Show simple item record

FieldValueLanguage
dc.contributor.authorDane, Chianna
dc.contributor.authorCumbers, Grace A.
dc.contributor.authorAllen, Beau
dc.contributor.authorMontgomery, Andrew P.
dc.contributor.authorDanon, Jonathan J.
dc.contributor.authorKassiou, Michael
dc.date.accessioned2024-08-30T05:40:21Z
dc.date.available2024-08-30T05:40:21Z
dc.date.issued2024en
dc.identifier.urihttps://hdl.handle.net/2123/33036
dc.description.abstractThe unique structural and physicochemical properties of adamantane and its derivatives have attracted considerable attention in the field of medicinal chemistry. Substituting phenyl rings for adamantane or its derivatives has provided a promising strategy to introduce lipophilicity and escape the ‘flat land’ of modern drug discovery. Additionally, the unique three-dimensional structure of adamantane facilitates the precise positioning of substituents allowing for a more effective exploration of drug targets. Evidently, we have seen an increased use of adamantane in pharmaceutically relevant molecules. The following Account highlights our group’s research in five drug discovery programs over the past 15 years showcasing the use of adamantane and its analogues in these studies.en
dc.language.isoenen
dc.publisherCSIRO Publishingen
dc.relation.ispartofAustralian Journal of Chemistryen
dc.rightsCreative Commons Attribution-NonCommercial-NoDerivatives 4.0en
dc.subjectadamantaneen
dc.subjectcannabinoid receptorsen
dc.subjectCNSen
dc.subjectmedicinal chemistryen
dc.subjectNMDA receptoren
dc.subjectP2X7 receptoren
dc.subjectsigma-2 receptoren
dc.subjectstructure–activity relationshipsen
dc.subjecttau aggregationen
dc.titleUnlocking therapeutic potential: the role of adamantane in drug discoveryen
dc.typeArticleen
dc.identifier.doi10.1071/CH24075
dc.type.pubtypePublisher's versionen
dc.rights.other© 2024 The Author(s) (or their employer(s)). Published by CSIRO Publishing. This is an open access article distributed under the Creative Commons AttributionNonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND)en
dc.relation.otherThe work presented herein was supported by the Australian Research Council and the National Health and Medical Research Council.
usyd.facultySeS faculties schools::Faculty of Science::School of Chemistryen
usyd.citation.volume77en
usyd.citation.issue8en
usyd.citation.spage1en
usyd.citation.epage16en
workflow.metadata.onlyNoen


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.